Long-term efficacy and safety of ustekinumab in refractory Crohn's disease patients: a multicenter retrospective experience - Université de Picardie Jules Verne Accéder directement au contenu
Communication Dans Un Congrès Journal of Crohn's and Colitis Année : 2017

Long-term efficacy and safety of ustekinumab in refractory Crohn's disease patients: a multicenter retrospective experience

Bernard Duclos
  • Fonction : Auteur
Mathurin Fumery
Fichier non déposé

Dates et versions

hal-03553341 , version 1 (02-02-2022)

Identifiants

Citer

Pauline Wils, Yoram Bouhnik, Pierre Michetti, Bernard Flourie, Hédia Brixi, et al.. Long-term efficacy and safety of ustekinumab in refractory Crohn's disease patients: a multicenter retrospective experience. 12. Congress of ECCO, European Crohn's and Colitis Organisation, Feb 2017, Barcelone, Spain. ⟨hal-03553341⟩
31 Consultations
0 Téléchargements

Partager

Gmail Facebook Twitter LinkedIn More